Vestavia Hills, AL2 Active Studies

Ankylosing Spondylitis Clinical Trials in Vestavia Hills, AL

Find 2 actively recruiting ankylosing spondylitis clinical trials in Vestavia Hills, AL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
15,228
Enrolling

Recruiting Ankylosing Spondylitis Studies in Vestavia Hills

About Ankylosing Spondylitis Clinical Trials in Vestavia Hills

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Vestavia Hills, AL. These studies are seeking a combined 15,228 participants. Research is being sponsored by AstraZeneca, Genentech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Vestavia Hills — FAQ

Are there ankylosing spondylitis clinical trials in Vestavia Hills?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Vestavia Hills, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Vestavia Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vestavia Hills research site will contact you about next steps.

Are clinical trials in Vestavia Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vestavia Hills studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Vestavia Hills are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov